New therapies for chronic obstructive pulmonary disease

Author： Krishna Ganesh Sankaranarayanan Viji Chitkara Rajinder K

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.3, 2004-03, pp. : 255-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease

By Belvisi Maria G Hele David J Birrell Mark A

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 265-285

Informa Healthcare

Access to resources Recommend Favorite

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

By Wagena E.J.

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 381-403

Adis International

Access to resources Recommend Favorite

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological and Dietary Antioxidant Therapies for Chronic Obstructive Pulmonary Disease

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1496-1530

Bentham Science Publishers

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite